- Our Work
- Get Involved
What next after shortened TB treatment fails in key trial?
Dr. Vidya Mave discusses the pros and cons of shortened tuberculosis treatment with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ).
"BPaMZ did exactly what it was supposed to – kill TB. She, however, also expressed concern over the high number of toxicity events."